Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.95 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.95 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.95 |
High Similarity |
NPD6166 |
Phase 2 |
0.9299 |
High Similarity |
NPD2801 |
Approved |
0.9236 |
High Similarity |
NPD1934 |
Approved |
0.9091 |
High Similarity |
NPD7054 |
Approved |
0.9062 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.9057 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.9036 |
High Similarity |
NPD7472 |
Approved |
0.9036 |
High Similarity |
NPD7074 |
Phase 3 |
0.903 |
High Similarity |
NPD3818 |
Discontinued |
0.8988 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8869 |
High Similarity |
NPD6797 |
Phase 2 |
0.8868 |
High Similarity |
NPD4380 |
Phase 2 |
0.8827 |
High Similarity |
NPD3882 |
Suspended |
0.8817 |
High Similarity |
NPD7251 |
Discontinued |
0.878 |
High Similarity |
NPD5494 |
Approved |
0.8773 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8765 |
High Similarity |
NPD7808 |
Phase 3 |
0.8757 |
High Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8726 |
High Similarity |
NPD1511 |
Approved |
0.865 |
High Similarity |
NPD3817 |
Phase 2 |
0.8639 |
High Similarity |
NPD5844 |
Phase 1 |
0.8616 |
High Similarity |
NPD1512 |
Approved |
0.8537 |
High Similarity |
NPD5402 |
Approved |
0.8438 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8434 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8424 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8421 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8408 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8393 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8354 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8344 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8344 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8343 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8323 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8304 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8303 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.828 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8253 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8253 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8217 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8171 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8156 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8144 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.814 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.811 |
Intermediate Similarity |
NPD5403 |
Approved |
0.807 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8037 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7988 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7977 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7967 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7962 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7962 |
Intermediate Similarity |
NPD943 |
Approved |
0.7962 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7962 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7952 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7943 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7895 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7892 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7862 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7857 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7836 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7816 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7805 |
Intermediate Similarity |
NPD6190 |
Approved |
0.779 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7778 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7771 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7759 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7746 |
Intermediate Similarity |
NPD919 |
Approved |
0.7744 |
Intermediate Similarity |
NPD3750 |
Approved |
0.774 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7716 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7707 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7688 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7683 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7672 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7672 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7672 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7672 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7672 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7672 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7672 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7667 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7644 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7643 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7636 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7622 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7606 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7579 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7578 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7571 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7558 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7558 |
Intermediate Similarity |
NPD37 |
Approved |
0.7554 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7552 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7538 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.753 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7529 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7529 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7529 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7513 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7513 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7484 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7471 |
Intermediate Similarity |
NPD920 |
Approved |
0.747 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7462 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7462 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7461 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7461 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7461 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7456 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7456 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7456 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7456 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7455 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7439 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7439 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7432 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7421 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7418 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7409 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7407 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7407 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7398 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7391 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7366 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7362 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7353 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7337 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7323 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7323 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7316 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7316 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7314 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7308 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7292 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7292 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7289 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7289 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7286 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7284 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7283 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7283 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7278 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7262 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7261 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7246 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7239 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7235 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7229 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7229 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7212 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7182 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7178 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7175 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7173 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7173 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7173 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7167 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7118 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7097 |
Intermediate Similarity |
NPD7039 |
Approved |
0.7097 |
Intermediate Similarity |
NPD7038 |
Approved |
0.7086 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7081 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7059 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7053 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7049 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7048 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7044 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7037 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7033 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7033 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7033 |
Intermediate Similarity |
NPD5710 |
Approved |
0.702 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7016 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7006 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7006 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7006 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.6994 |
Remote Similarity |
NPD7213 |
Phase 3 |
0.6994 |
Remote Similarity |
NPD7212 |
Phase 2 |
0.699
|
Remote Similarity |
NPD7237 |
Clinical (unspecified phase) |